Brain natriuretic peptide and QRS duration as a predictor for cardiac events in patients with heart failure

Journal of Cardiology

Volumn 47, Issue 6, 2006, Pages 277-283

  Taniguchi, Takuya ^a,b   Kawasaki, Tatsuya ^a   Miyai, Nobuyuki ^a   Kamitani, Tadaaki ^a   Kawasaki, Shingo ^a   Sugihara, Hiroki ^a  

^a MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Electrocardiography (QRS duration); Heart failure; Natriuretic peptides, brain; Prognosis; Sudden death

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE COURSE; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; QRS COMPLEX; SUDDEN DEATH; BLOOD; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 33745798872     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bonneux L, Barendregt JJ, Meeter K, Bonsel GJ, van der Maas PJ: Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: The future rise of the heart failure. Am J Public Health 1994: 84; 20-28
2. Jessup M, Brozena S: Heart failure. N Engl J Med 2003; 348: 2007-2018
3. Schrier RW, Abraham WT: Hormones and hemodynamics in heart failure. N Engl J Med 1999; 341: 577-585
4. Maisel AS, Krishnaswamy P, Nowak RM, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AHB, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, for the Breathing Not Properly Multinational Study Investigators: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167
5. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M: Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-516
6. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM: Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355: 1126-1130
7. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-663
8. Hombach V: Electrocardiogram of the failing heart. Card Electrophysiol Rev 2002; 6: 209-214
9. Kashani A, Barold SS: Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005; 46: 2183-2192
10. Shamim W, Yousufuddin M, Cicoria M, Gibson DG, Coats AJ, Henein MY: Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart 2002; 88: 47-51
11. Amiya E, Tanabe K, Ikari Y, Nakajima Y, Hara K: Prolonged QRS duration and severity of mitral regurgitation are unfavorable prognostic markers of heart failure in patients with nonischemic dilated cardiomyopathy. Circ J 2006; 70: 57-62
12. Bader H, Garrigue S, Lafitte S, Reuter S, Jais P, Haïssaguerre M, Bonnet J, Clementy J, Roudant R: Intra-left ventricular electromechanical asynchrony: A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 2004; 43: 248-256
13. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J, for the MIRACLE Study Group: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853
14. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549
15. Krüger S, Filzmaier K, Graf J, Kunz D, Stickel T, Hoffmann R, Hanrath P, Janssens U: QRS prolongation on surface ECG and brain natriuretic peptide as indicators of left ventricular systolic dysfunction. J Int Med 2004; 255: 206-212
16. McKee PA, Castelli WP, McNamara PM, Kannel WB: The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441-1446
17. Kim SG, Fogoros RN, Furman S, Connolly SJ, Kuck KH, Moss AJ: Standardized reporting of ICD patient outcome: The report of a North American Society of Pacing and Electrophysiology Policy Conference, February 9-10, 1993. Pacing Clin Electrophysiol 1993; 16: 1358-1362
18. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC: Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004; 43: 635-641
19. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, Pacher R: B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002; 105: 2392-2397
20. Vrtovec B, Delgado R, Zewail A, Thomas CD, Richartz BM, Radovancevic B: Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 2003; 107: 1764-1769
21. Gang Y, Ono T, Hnatkova K, Hashimoto K, Camm AJ, Pitt B, Poole-Wilson PA, Malik M, for the ELITE II investigators: QT dispersion has no prognostic value in patients with symptomatic heart failure: An ELITE II substudy. Pacing Clin Electrophysiol 2003; 26: 394-400
22. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN, for the Department of Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure: QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002; 143: 1085-1091
23. Baldasseroni S, Opasich C, Gorini M, Lucci D, Marchionni N, Marini M, Campana C, Perini G, Deorsola A, Masotti G, Tavazzi L, Maggioni AP, for the Italian Network on Congestive Heart Failure Investigators: Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: A report from the Italian network on congestive heart failure. Am Heart J 2002; 143: 398-405
24. Kearney MT, Fox KA, Lee AJ, Brooksby WP, Shah AM, Flapan A, Prescott RJ, Andrews R, Batin PD, Eckberg DL, Gall N, Zaman AG, Lindsay HS, Nolan J: Predicting sudden death in patients with mild to moderate chronic heart failure. Heart 2004; 90: 1137-1143